Facetten
Zugriff
Einrichtung
Medientyp
- Text 13
Karte
Erscheinungsjahr
Autor/in
- Warren, R B
- Reich, K 9
- Puig, L 4
- Blauvelt, A 3
- Brock, F 3
- alle zeigen
Sprache
13 Einträge gefunden
-
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2)
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
-
-
-
Psoriasis: is the impairment to a patient's life cumulative?
2010 - Forschungsinformationssystem des UKE